Literature DB >> 22262042

ENETS 2011 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: an update.

Ramon Salazar1, Bertram Wiedenmann, Guido Rindi, Philippe Ruszniewski.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22262042     DOI： 10.1159/000335600

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN： 0028-3835            Impact factor:   4.914


× No keyword cloud information.
  18 in total

Review 1.  Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.

Authors:  Zu-Yi Ma; Yuan-Feng Gong; Hong-Kai Zhuang; Zi-Xuan Zhou; Shan-Zhou Huang; Yi-Ping Zou; Bo-Wen Huang; Zhong-Hai Sun; Chuan-Zhao Zhang; Yun-Qiang Tang; Bao-Hua Hou
Journal:  World J Gastroenterol       Date:  2020-05-21       Impact factor: 5.742

Review 2.  [Neuroendocrine neoplasms of the distal jejunum and ileum].

Authors:  M Anlauf; B Sipos; I Boeck; S E Baldus; S Heikaus; M Krausch; W T Knoefel; N Begum; P Goretzki; M Schott; C J Auernhammer; B Cremer; A Rinke; S Ezziddin; C Fottner; G Pöpperl; H Lahner; D Hörsch; H E Gabbert; P Komminoth; A Perren; G Klöppel; B Wiedenmann; M Pavel; U Pape
Journal:  Pathologe       Date:  2014-05       Impact factor: 1.011

3.  Diagnostic accuracy of endoscopic ultrasonography for rectal neuroendocrine neoplasms.

Authors:  Hong-Tan Chen; Guo-Qiang Xu; Xiao-Dong Teng; Yi-Peng Chen; Li-Hua Chen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

4.  Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest).

Authors:  Irvin M Modlin; Mark Kidd; Kjell Oberg; Massimo Falconi; Pier Luigi Filosso; Andrea Frilling; Anna Malczewska; Ronald Salem; Christos Toumpanakis; Faidon-Marios Laskaratos; Stefano Partelli; Matteo Roffinella; Claudia von Arx; Beata Kos Kudla; Lisa Bodei; Ignat A Drozdov; Alexandra Kitz
Journal:  Ann Surg Oncol       Date:  2021-05-18       Impact factor: 5.344

5.  Analysis of Prognostic Risk Factors of Endoscopic Submucosal Dissection (ESD) and Curative Resection of Gastrointestinal Neuroendocrine Neoplasms.

Authors:  Yuan Si; ChaoKang Huang; JingBin Yuan; XianHui Zhang; QingQiang He; ZhiJin Lin; Ling He; ZhongXin Liu
Journal:  Contrast Media Mol Imaging       Date:  2022-07-08       Impact factor: 3.009

Review 6.  Neuroendocrine tumours: the role of imaging for diagnosis and therapy.

Authors:  Martijn van Essen; Anders Sundin; Eric P Krenning; Dik J Kwekkeboom
Journal:  Nat Rev Endocrinol       Date:  2013-12-10       Impact factor: 43.330

Review 7.  Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis.

Authors:  Håkan Geijer; Lars H Breimer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-20       Impact factor: 9.236

8.  Macroscopic morphology for estimation of malignant potential in pancreatic neuroendocrine neoplasm.

Authors:  Eriko Katsuta; Atsushi Kudo; Takumi Akashi; Yusuke Mitsunori; Satoshi Matsumura; Arihiro Aihara; Daisuke Ban; Takanori Ochiai; Shinji Tanaka; Yoshinobu Eishi; Minoru Tanabe
Journal:  J Cancer Res Clin Oncol       Date:  2016-02-17       Impact factor: 4.553

Review 9.  The 2010 WHO classification of digestive neuroendocrine neoplasms: a critical appraisal four years after its introduction.

Authors:  G Rindi; G Petrone; F Inzani
Journal:  Endocr Pathol       Date:  2014-06       Impact factor: 3.943

10.  Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.

Authors:  Andrew R Moore; Malcolm Boyce; Islay A Steele; Fiona Campbell; Andrea Varro; D Mark Pritchard
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.